Want to see SE:SCIB full AI Analyst Report?
SCIB Stock Chart & Stats
kr0.33
>-kr0.01(-1.65%)
At close: 4:00 PM EST
kr0.33
>-kr0.01(-1.65%)
Day’s Range― - ―
52-Week Rangekr16.67 - kr54.00
Previous CloseN/A
Volume1.41K
Average Volume (3M)318.73K
Market Cap
kr224.96M
Enterprise Valuekr318.37
Total Cash (Recent Filing)kr37.15M
Total Debt (Recent Filing)kr23.21M
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.91
Shares Outstanding10,225,300
10 Day Avg. Volume218,776
30 Day Avg. Volume318,725
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)18.68
Price to Sales (P/S)3.07
P/FCF Ratio-1.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.33
Revenue Forecast (FY)kr65.90M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthTTM revenue growth and steady multi-year expansion indicate increasing adoption of the Nevisense platform and a broader commercial base. If sustained, this can improve operating leverage over time, although scale has not yet reached profitability.
Gross MarginA gross margin near 59% suggests the product retains meaningful value after direct costs. Maintaining this level as sales grow could support future operating leverage and provide a foundation for profitability once the company reaches greater commercial scale.
Recurring Revenue ModelThe model combines upfront device placements with consumables, procedure-linked items, service, training and support. This can create repeat customer activity and a more durable revenue base than one-off equipment sales if utilization expands.
Bears Say
Persistent LossesDeep net and operating losses show that the cost base remains far ahead of current revenue scale. Unless growth translates into substantial operating leverage, continuing losses may constrain investment capacity and prolong the path to self-sustaining profitability.
Cash BurnMaterially negative operating and free cash flow indicate that the business is not yet funding operations internally. Continued cash burn increases dependence on external capital, potentially limiting strategic flexibility and creating dilution or refinancing risk.
Balance Sheet VolatilityAlthough current leverage is moderate, the sharp historical swing shows that losses can materially weaken the equity base and alter financing risk. If operating losses persist, the company may again require external funding under less favorable conditions.
SciBase Holding AB News
SCIB FAQ
What was SciBase Holding AB’s price range in the past 12 months?
SciBase Holding AB lowest stock price was kr16.67 and its highest was kr54.00 in the past 12 months.
What is SciBase Holding AB’s market cap?
SciBase Holding AB’s market cap is kr224.96M.
When is SciBase Holding AB’s upcoming earnings report date?
SciBase Holding AB’s upcoming earnings report date is Nov 12, 2026 which is in 80 days.
How were SciBase Holding AB’s earnings last quarter?
SciBase Holding AB released its earnings results on Aug 19, 2026. The company reported -kr2.83 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is SciBase Holding AB overvalued?
According to Wall Street analysts SciBase Holding AB’s price is currently Overvalued.
Does SciBase Holding AB pay dividends?
SciBase Holding AB does not currently pay dividends.
What is SciBase Holding AB’s EPS estimate?
SciBase Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SciBase Holding AB have?
SciBase Holding AB has 10,225,300 shares outstanding.
What happened to SciBase Holding AB’s price movement after its last earnings report?
SciBase Holding AB reported an EPS of -kr2.83 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.364%.
Which hedge fund is a major shareholder of SciBase Holding AB?
Currently, no hedge funds are holding shares in SE:SCIB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SciBase Holding AB
SciBase Holding AB (publ), a medical technology firm founded in 1998 and headquartered in Sundbyberg, Sweden, specializes in the global development and distribution of instruments for diagnosing skin cancer and other dermatological issues. Their key offerings, Nevisense and Nevisense Go, comprise a point-of-care platform designed for the detection of melanoma and non-melanoma skin cancers, as well as for evaluating skin barrier function. The company also maintains a collaborative agreement with the Advanced Dermatology and Cosmetic Surgery (ADCS) group.